Page last updated: 2024-10-25

clenbuterol and Glaucoma

clenbuterol has been researched along with Glaucoma in 1 studies

Clenbuterol: A substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma.
clenbuterol : A substituted aniline that is 2,6-dichloroaniline in which the hydrogen at position 4 has been replaced by a 2-(tert-butylamino)-1-hydroxyethyl group.

Glaucoma: An ocular disease, occurring in many forms, having as its primary characteristics an unstable or a sustained increase in the intraocular pressure which the eye cannot withstand without damage to its structure or impairment of its function. The consequences of the increased pressure may be manifested in a variety of symptoms, depending upon type and severity, such as excavation of the optic disk, hardness of the eyeball, corneal anesthesia, reduced visual acuity, seeing of colored halos around lights, disturbed dark adaptation, visual field defects, and headaches. (Dictionary of Visual Science, 4th ed)

Research Excerpts

ExcerptRelevanceReference
"As neurodegenerative disorder, Alzheimer's Disease (AD) is postulated to share a common molecular mechanism with glaucoma."1.72Glaucoma and Alzheimer: Neurodegenerative disorders show an adrenergic dysbalance. ( Hohberger, B; Lämmer, R; Mardin, C; Müller, J; Prüss, H; Wallukat, G, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Hohberger, B1
Prüss, H1
Mardin, C1
Lämmer, R1
Müller, J1
Wallukat, G1

Other Studies

1 other study available for clenbuterol and Glaucoma

ArticleYear
Glaucoma and Alzheimer: Neurodegenerative disorders show an adrenergic dysbalance.
    PloS one, 2022, Volume: 17, Issue:10

    Topics: Adrenergic Agents; Alzheimer Disease; Amyloid beta-Peptides; Animals; Autoantibodies; Clenbuterol; G

2022